Medical Care
Global Cancer Therapy and Testing Market Research Report 2025
- May 12, 25
- ID: 234521
- Pages: 82
- Figures: 85
- Views: 5
The global market for Cancer Therapy and Testing was valued at US$ 885040 million in the year 2024 and is projected to reach a revised size of US$ 2070820 million by 2031, growing at a CAGR of 13.1% during the forecast period.
Cancer Therapy and Testing
The cancer therapy and testing market has been witnessing significant growth over the years and is expected to continue expanding in the future. Several factors contribute to this market growth, including the increasing incidence of cancer globally, advancements in diagnostic technologies, personalized medicine approaches, and a growing emphasis on early detection and targeted therapies.
This report aims to provide a comprehensive presentation of the global market for Cancer Therapy and Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Therapy and Testing.
The Cancer Therapy and Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Therapy and Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Therapy and Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Invitae
Foundation Medicine
Guardant Health
Illumina
Sysmex
Abingdon Health
Sophia
NanoEntek
BGI
Diagnosis
Exact Sciences
AstraZeneca
Bayer AG
Johnson & Johnson
Pfizer Inc.
Segment by Type
Cancer Detection
Cancer Treatment
Segment by Application
Lung Cancer
Rectal Cancer
Breast Cancer
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Therapy and Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cancer Therapy and Testing
The cancer therapy and testing market has been witnessing significant growth over the years and is expected to continue expanding in the future. Several factors contribute to this market growth, including the increasing incidence of cancer globally, advancements in diagnostic technologies, personalized medicine approaches, and a growing emphasis on early detection and targeted therapies.
This report aims to provide a comprehensive presentation of the global market for Cancer Therapy and Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Therapy and Testing.
The Cancer Therapy and Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Therapy and Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Therapy and Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Invitae
Foundation Medicine
Guardant Health
Illumina
Sysmex
Abingdon Health
Sophia
NanoEntek
BGI
Diagnosis
Exact Sciences
AstraZeneca
Bayer AG
Johnson & Johnson
Pfizer Inc.
Segment by Type
Cancer Detection
Cancer Treatment
Segment by Application
Lung Cancer
Rectal Cancer
Breast Cancer
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Therapy and Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Therapy and Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cancer Detection
1.2.3 Cancer Treatment
1.3 Market by Application
1.3.1 Global Cancer Therapy and Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Lung Cancer
1.3.3 Rectal Cancer
1.3.4 Breast Cancer
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Therapy and Testing Market Perspective (2020-2031)
2.2 Global Cancer Therapy and Testing Growth Trends by Region
2.2.1 Global Cancer Therapy and Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Therapy and Testing Historic Market Size by Region (2020-2025)
2.2.3 Cancer Therapy and Testing Forecasted Market Size by Region (2026-2031)
2.3 Cancer Therapy and Testing Market Dynamics
2.3.1 Cancer Therapy and Testing Industry Trends
2.3.2 Cancer Therapy and Testing Market Drivers
2.3.3 Cancer Therapy and Testing Market Challenges
2.3.4 Cancer Therapy and Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Therapy and Testing Players by Revenue
3.1.1 Global Top Cancer Therapy and Testing Players by Revenue (2020-2025)
3.1.2 Global Cancer Therapy and Testing Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Therapy and Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Therapy and Testing Revenue
3.4 Global Cancer Therapy and Testing Market Concentration Ratio
3.4.1 Global Cancer Therapy and Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Therapy and Testing Revenue in 2024
3.5 Global Key Players of Cancer Therapy and Testing Head office and Area Served
3.6 Global Key Players of Cancer Therapy and Testing, Product and Application
3.7 Global Key Players of Cancer Therapy and Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Therapy and Testing Breakdown Data by Type
4.1 Global Cancer Therapy and Testing Historic Market Size by Type (2020-2025)
4.2 Global Cancer Therapy and Testing Forecasted Market Size by Type (2026-2031)
5 Cancer Therapy and Testing Breakdown Data by Application
5.1 Global Cancer Therapy and Testing Historic Market Size by Application (2020-2025)
5.2 Global Cancer Therapy and Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Therapy and Testing Market Size (2020-2031)
6.2 North America Cancer Therapy and Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Therapy and Testing Market Size by Country (2020-2025)
6.4 North America Cancer Therapy and Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Therapy and Testing Market Size (2020-2031)
7.2 Europe Cancer Therapy and Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Therapy and Testing Market Size by Country (2020-2025)
7.4 Europe Cancer Therapy and Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Therapy and Testing Market Size (2020-2031)
8.2 Asia-Pacific Cancer Therapy and Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Therapy and Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Therapy and Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Therapy and Testing Market Size (2020-2031)
9.2 Latin America Cancer Therapy and Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Therapy and Testing Market Size by Country (2020-2025)
9.4 Latin America Cancer Therapy and Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Therapy and Testing Market Size (2020-2031)
10.2 Middle East & Africa Cancer Therapy and Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Therapy and Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Therapy and Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Invitae
11.1.1 Invitae Company Details
11.1.2 Invitae Business Overview
11.1.3 Invitae Cancer Therapy and Testing Introduction
11.1.4 Invitae Revenue in Cancer Therapy and Testing Business (2020-2025)
11.1.5 Invitae Recent Development
11.2 Foundation Medicine
11.2.1 Foundation Medicine Company Details
11.2.2 Foundation Medicine Business Overview
11.2.3 Foundation Medicine Cancer Therapy and Testing Introduction
11.2.4 Foundation Medicine Revenue in Cancer Therapy and Testing Business (2020-2025)
11.2.5 Foundation Medicine Recent Development
11.3 Guardant Health
11.3.1 Guardant Health Company Details
11.3.2 Guardant Health Business Overview
11.3.3 Guardant Health Cancer Therapy and Testing Introduction
11.3.4 Guardant Health Revenue in Cancer Therapy and Testing Business (2020-2025)
11.3.5 Guardant Health Recent Development
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Illumina Business Overview
11.4.3 Illumina Cancer Therapy and Testing Introduction
11.4.4 Illumina Revenue in Cancer Therapy and Testing Business (2020-2025)
11.4.5 Illumina Recent Development
11.5 Sysmex
11.5.1 Sysmex Company Details
11.5.2 Sysmex Business Overview
11.5.3 Sysmex Cancer Therapy and Testing Introduction
11.5.4 Sysmex Revenue in Cancer Therapy and Testing Business (2020-2025)
11.5.5 Sysmex Recent Development
11.6 Abingdon Health
11.6.1 Abingdon Health Company Details
11.6.2 Abingdon Health Business Overview
11.6.3 Abingdon Health Cancer Therapy and Testing Introduction
11.6.4 Abingdon Health Revenue in Cancer Therapy and Testing Business (2020-2025)
11.6.5 Abingdon Health Recent Development
11.7 Sophia
11.7.1 Sophia Company Details
11.7.2 Sophia Business Overview
11.7.3 Sophia Cancer Therapy and Testing Introduction
11.7.4 Sophia Revenue in Cancer Therapy and Testing Business (2020-2025)
11.7.5 Sophia Recent Development
11.8 NanoEntek
11.8.1 NanoEntek Company Details
11.8.2 NanoEntek Business Overview
11.8.3 NanoEntek Cancer Therapy and Testing Introduction
11.8.4 NanoEntek Revenue in Cancer Therapy and Testing Business (2020-2025)
11.8.5 NanoEntek Recent Development
11.9 BGI
11.9.1 BGI Company Details
11.9.2 BGI Business Overview
11.9.3 BGI Cancer Therapy and Testing Introduction
11.9.4 BGI Revenue in Cancer Therapy and Testing Business (2020-2025)
11.9.5 BGI Recent Development
11.10 Diagnosis
11.10.1 Diagnosis Company Details
11.10.2 Diagnosis Business Overview
11.10.3 Diagnosis Cancer Therapy and Testing Introduction
11.10.4 Diagnosis Revenue in Cancer Therapy and Testing Business (2020-2025)
11.10.5 Diagnosis Recent Development
11.11 Exact Sciences
11.11.1 Exact Sciences Company Details
11.11.2 Exact Sciences Business Overview
11.11.3 Exact Sciences Cancer Therapy and Testing Introduction
11.11.4 Exact Sciences Revenue in Cancer Therapy and Testing Business (2020-2025)
11.11.5 Exact Sciences Recent Development
11.12 AstraZeneca
11.12.1 AstraZeneca Company Details
11.12.2 AstraZeneca Business Overview
11.12.3 AstraZeneca Cancer Therapy and Testing Introduction
11.12.4 AstraZeneca Revenue in Cancer Therapy and Testing Business (2020-2025)
11.12.5 AstraZeneca Recent Development
11.13 Bayer AG
11.13.1 Bayer AG Company Details
11.13.2 Bayer AG Business Overview
11.13.3 Bayer AG Cancer Therapy and Testing Introduction
11.13.4 Bayer AG Revenue in Cancer Therapy and Testing Business (2020-2025)
11.13.5 Bayer AG Recent Development
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Details
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Cancer Therapy and Testing Introduction
11.14.4 Johnson & Johnson Revenue in Cancer Therapy and Testing Business (2020-2025)
11.14.5 Johnson & Johnson Recent Development
11.15 Pfizer Inc.
11.15.1 Pfizer Inc. Company Details
11.15.2 Pfizer Inc. Business Overview
11.15.3 Pfizer Inc. Cancer Therapy and Testing Introduction
11.15.4 Pfizer Inc. Revenue in Cancer Therapy and Testing Business (2020-2025)
11.15.5 Pfizer Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Therapy and Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cancer Detection
1.2.3 Cancer Treatment
1.3 Market by Application
1.3.1 Global Cancer Therapy and Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Lung Cancer
1.3.3 Rectal Cancer
1.3.4 Breast Cancer
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Therapy and Testing Market Perspective (2020-2031)
2.2 Global Cancer Therapy and Testing Growth Trends by Region
2.2.1 Global Cancer Therapy and Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Therapy and Testing Historic Market Size by Region (2020-2025)
2.2.3 Cancer Therapy and Testing Forecasted Market Size by Region (2026-2031)
2.3 Cancer Therapy and Testing Market Dynamics
2.3.1 Cancer Therapy and Testing Industry Trends
2.3.2 Cancer Therapy and Testing Market Drivers
2.3.3 Cancer Therapy and Testing Market Challenges
2.3.4 Cancer Therapy and Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Therapy and Testing Players by Revenue
3.1.1 Global Top Cancer Therapy and Testing Players by Revenue (2020-2025)
3.1.2 Global Cancer Therapy and Testing Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Therapy and Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Therapy and Testing Revenue
3.4 Global Cancer Therapy and Testing Market Concentration Ratio
3.4.1 Global Cancer Therapy and Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Therapy and Testing Revenue in 2024
3.5 Global Key Players of Cancer Therapy and Testing Head office and Area Served
3.6 Global Key Players of Cancer Therapy and Testing, Product and Application
3.7 Global Key Players of Cancer Therapy and Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Therapy and Testing Breakdown Data by Type
4.1 Global Cancer Therapy and Testing Historic Market Size by Type (2020-2025)
4.2 Global Cancer Therapy and Testing Forecasted Market Size by Type (2026-2031)
5 Cancer Therapy and Testing Breakdown Data by Application
5.1 Global Cancer Therapy and Testing Historic Market Size by Application (2020-2025)
5.2 Global Cancer Therapy and Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Therapy and Testing Market Size (2020-2031)
6.2 North America Cancer Therapy and Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Therapy and Testing Market Size by Country (2020-2025)
6.4 North America Cancer Therapy and Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Therapy and Testing Market Size (2020-2031)
7.2 Europe Cancer Therapy and Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Therapy and Testing Market Size by Country (2020-2025)
7.4 Europe Cancer Therapy and Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Therapy and Testing Market Size (2020-2031)
8.2 Asia-Pacific Cancer Therapy and Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Therapy and Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Therapy and Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Therapy and Testing Market Size (2020-2031)
9.2 Latin America Cancer Therapy and Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Therapy and Testing Market Size by Country (2020-2025)
9.4 Latin America Cancer Therapy and Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Therapy and Testing Market Size (2020-2031)
10.2 Middle East & Africa Cancer Therapy and Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Therapy and Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Therapy and Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Invitae
11.1.1 Invitae Company Details
11.1.2 Invitae Business Overview
11.1.3 Invitae Cancer Therapy and Testing Introduction
11.1.4 Invitae Revenue in Cancer Therapy and Testing Business (2020-2025)
11.1.5 Invitae Recent Development
11.2 Foundation Medicine
11.2.1 Foundation Medicine Company Details
11.2.2 Foundation Medicine Business Overview
11.2.3 Foundation Medicine Cancer Therapy and Testing Introduction
11.2.4 Foundation Medicine Revenue in Cancer Therapy and Testing Business (2020-2025)
11.2.5 Foundation Medicine Recent Development
11.3 Guardant Health
11.3.1 Guardant Health Company Details
11.3.2 Guardant Health Business Overview
11.3.3 Guardant Health Cancer Therapy and Testing Introduction
11.3.4 Guardant Health Revenue in Cancer Therapy and Testing Business (2020-2025)
11.3.5 Guardant Health Recent Development
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Illumina Business Overview
11.4.3 Illumina Cancer Therapy and Testing Introduction
11.4.4 Illumina Revenue in Cancer Therapy and Testing Business (2020-2025)
11.4.5 Illumina Recent Development
11.5 Sysmex
11.5.1 Sysmex Company Details
11.5.2 Sysmex Business Overview
11.5.3 Sysmex Cancer Therapy and Testing Introduction
11.5.4 Sysmex Revenue in Cancer Therapy and Testing Business (2020-2025)
11.5.5 Sysmex Recent Development
11.6 Abingdon Health
11.6.1 Abingdon Health Company Details
11.6.2 Abingdon Health Business Overview
11.6.3 Abingdon Health Cancer Therapy and Testing Introduction
11.6.4 Abingdon Health Revenue in Cancer Therapy and Testing Business (2020-2025)
11.6.5 Abingdon Health Recent Development
11.7 Sophia
11.7.1 Sophia Company Details
11.7.2 Sophia Business Overview
11.7.3 Sophia Cancer Therapy and Testing Introduction
11.7.4 Sophia Revenue in Cancer Therapy and Testing Business (2020-2025)
11.7.5 Sophia Recent Development
11.8 NanoEntek
11.8.1 NanoEntek Company Details
11.8.2 NanoEntek Business Overview
11.8.3 NanoEntek Cancer Therapy and Testing Introduction
11.8.4 NanoEntek Revenue in Cancer Therapy and Testing Business (2020-2025)
11.8.5 NanoEntek Recent Development
11.9 BGI
11.9.1 BGI Company Details
11.9.2 BGI Business Overview
11.9.3 BGI Cancer Therapy and Testing Introduction
11.9.4 BGI Revenue in Cancer Therapy and Testing Business (2020-2025)
11.9.5 BGI Recent Development
11.10 Diagnosis
11.10.1 Diagnosis Company Details
11.10.2 Diagnosis Business Overview
11.10.3 Diagnosis Cancer Therapy and Testing Introduction
11.10.4 Diagnosis Revenue in Cancer Therapy and Testing Business (2020-2025)
11.10.5 Diagnosis Recent Development
11.11 Exact Sciences
11.11.1 Exact Sciences Company Details
11.11.2 Exact Sciences Business Overview
11.11.3 Exact Sciences Cancer Therapy and Testing Introduction
11.11.4 Exact Sciences Revenue in Cancer Therapy and Testing Business (2020-2025)
11.11.5 Exact Sciences Recent Development
11.12 AstraZeneca
11.12.1 AstraZeneca Company Details
11.12.2 AstraZeneca Business Overview
11.12.3 AstraZeneca Cancer Therapy and Testing Introduction
11.12.4 AstraZeneca Revenue in Cancer Therapy and Testing Business (2020-2025)
11.12.5 AstraZeneca Recent Development
11.13 Bayer AG
11.13.1 Bayer AG Company Details
11.13.2 Bayer AG Business Overview
11.13.3 Bayer AG Cancer Therapy and Testing Introduction
11.13.4 Bayer AG Revenue in Cancer Therapy and Testing Business (2020-2025)
11.13.5 Bayer AG Recent Development
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Details
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Cancer Therapy and Testing Introduction
11.14.4 Johnson & Johnson Revenue in Cancer Therapy and Testing Business (2020-2025)
11.14.5 Johnson & Johnson Recent Development
11.15 Pfizer Inc.
11.15.1 Pfizer Inc. Company Details
11.15.2 Pfizer Inc. Business Overview
11.15.3 Pfizer Inc. Cancer Therapy and Testing Introduction
11.15.4 Pfizer Inc. Revenue in Cancer Therapy and Testing Business (2020-2025)
11.15.5 Pfizer Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cancer Therapy and Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cancer Detection
Table 3. Key Players of Cancer Treatment
Table 4. Global Cancer Therapy and Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Cancer Therapy and Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Cancer Therapy and Testing Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Cancer Therapy and Testing Market Share by Region (2020-2025)
Table 8. Global Cancer Therapy and Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Cancer Therapy and Testing Market Share by Region (2026-2031)
Table 10. Cancer Therapy and Testing Market Trends
Table 11. Cancer Therapy and Testing Market Drivers
Table 12. Cancer Therapy and Testing Market Challenges
Table 13. Cancer Therapy and Testing Market Restraints
Table 14. Global Cancer Therapy and Testing Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Cancer Therapy and Testing Market Share by Players (2020-2025)
Table 16. Global Top Cancer Therapy and Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Therapy and Testing as of 2024)
Table 17. Ranking of Global Top Cancer Therapy and Testing Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Cancer Therapy and Testing Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Cancer Therapy and Testing, Headquarters and Area Served
Table 20. Global Key Players of Cancer Therapy and Testing, Product and Application
Table 21. Global Key Players of Cancer Therapy and Testing, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Therapy and Testing Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Cancer Therapy and Testing Revenue Market Share by Type (2020-2025)
Table 25. Global Cancer Therapy and Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Cancer Therapy and Testing Revenue Market Share by Type (2026-2031)
Table 27. Global Cancer Therapy and Testing Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Cancer Therapy and Testing Revenue Market Share by Application (2020-2025)
Table 29. Global Cancer Therapy and Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Cancer Therapy and Testing Revenue Market Share by Application (2026-2031)
Table 31. North America Cancer Therapy and Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Cancer Therapy and Testing Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Cancer Therapy and Testing Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Cancer Therapy and Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Cancer Therapy and Testing Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Cancer Therapy and Testing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Cancer Therapy and Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Cancer Therapy and Testing Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Cancer Therapy and Testing Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cancer Therapy and Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Cancer Therapy and Testing Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Cancer Therapy and Testing Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Cancer Therapy and Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Cancer Therapy and Testing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Cancer Therapy and Testing Market Size by Country (2026-2031) & (US$ Million)
Table 46. Invitae Company Details
Table 47. Invitae Business Overview
Table 48. Invitae Cancer Therapy and Testing Product
Table 49. Invitae Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 50. Invitae Recent Development
Table 51. Foundation Medicine Company Details
Table 52. Foundation Medicine Business Overview
Table 53. Foundation Medicine Cancer Therapy and Testing Product
Table 54. Foundation Medicine Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 55. Foundation Medicine Recent Development
Table 56. Guardant Health Company Details
Table 57. Guardant Health Business Overview
Table 58. Guardant Health Cancer Therapy and Testing Product
Table 59. Guardant Health Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 60. Guardant Health Recent Development
Table 61. Illumina Company Details
Table 62. Illumina Business Overview
Table 63. Illumina Cancer Therapy and Testing Product
Table 64. Illumina Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 65. Illumina Recent Development
Table 66. Sysmex Company Details
Table 67. Sysmex Business Overview
Table 68. Sysmex Cancer Therapy and Testing Product
Table 69. Sysmex Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 70. Sysmex Recent Development
Table 71. Abingdon Health Company Details
Table 72. Abingdon Health Business Overview
Table 73. Abingdon Health Cancer Therapy and Testing Product
Table 74. Abingdon Health Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 75. Abingdon Health Recent Development
Table 76. Sophia Company Details
Table 77. Sophia Business Overview
Table 78. Sophia Cancer Therapy and Testing Product
Table 79. Sophia Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 80. Sophia Recent Development
Table 81. NanoEntek Company Details
Table 82. NanoEntek Business Overview
Table 83. NanoEntek Cancer Therapy and Testing Product
Table 84. NanoEntek Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 85. NanoEntek Recent Development
Table 86. BGI Company Details
Table 87. BGI Business Overview
Table 88. BGI Cancer Therapy and Testing Product
Table 89. BGI Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 90. BGI Recent Development
Table 91. Diagnosis Company Details
Table 92. Diagnosis Business Overview
Table 93. Diagnosis Cancer Therapy and Testing Product
Table 94. Diagnosis Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 95. Diagnosis Recent Development
Table 96. Exact Sciences Company Details
Table 97. Exact Sciences Business Overview
Table 98. Exact Sciences Cancer Therapy and Testing Product
Table 99. Exact Sciences Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 100. Exact Sciences Recent Development
Table 101. AstraZeneca Company Details
Table 102. AstraZeneca Business Overview
Table 103. AstraZeneca Cancer Therapy and Testing Product
Table 104. AstraZeneca Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 105. AstraZeneca Recent Development
Table 106. Bayer AG Company Details
Table 107. Bayer AG Business Overview
Table 108. Bayer AG Cancer Therapy and Testing Product
Table 109. Bayer AG Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 110. Bayer AG Recent Development
Table 111. Johnson & Johnson Company Details
Table 112. Johnson & Johnson Business Overview
Table 113. Johnson & Johnson Cancer Therapy and Testing Product
Table 114. Johnson & Johnson Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 115. Johnson & Johnson Recent Development
Table 116. Pfizer Inc. Company Details
Table 117. Pfizer Inc. Business Overview
Table 118. Pfizer Inc. Cancer Therapy and Testing Product
Table 119. Pfizer Inc. Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 120. Pfizer Inc. Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Cancer Therapy and Testing Picture
Figure 2. Global Cancer Therapy and Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cancer Therapy and Testing Market Share by Type: 2024 VS 2031
Figure 4. Cancer Detection Features
Figure 5. Cancer Treatment Features
Figure 6. Global Cancer Therapy and Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Cancer Therapy and Testing Market Share by Application: 2024 VS 2031
Figure 8. Lung Cancer Case Studies
Figure 9. Rectal Cancer Case Studies
Figure 10. Breast Cancer Case Studies
Figure 11. Other Case Studies
Figure 12. Cancer Therapy and Testing Report Years Considered
Figure 13. Global Cancer Therapy and Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Cancer Therapy and Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Cancer Therapy and Testing Market Share by Region: 2024 VS 2031
Figure 16. Global Cancer Therapy and Testing Market Share by Players in 2024
Figure 17. Global Top Cancer Therapy and Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Therapy and Testing as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Cancer Therapy and Testing Revenue in 2024
Figure 19. North America Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Cancer Therapy and Testing Market Share by Country (2020-2031)
Figure 21. United States Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Cancer Therapy and Testing Market Share by Country (2020-2031)
Figure 25. Germany Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Cancer Therapy and Testing Market Share by Region (2020-2031)
Figure 33. China Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Cancer Therapy and Testing Market Share by Country (2020-2031)
Figure 41. Mexico Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Cancer Therapy and Testing Market Share by Country (2020-2031)
Figure 45. Turkey Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Invitae Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 49. Foundation Medicine Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 50. Guardant Health Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 51. Illumina Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 52. Sysmex Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 53. Abingdon Health Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 54. Sophia Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 55. NanoEntek Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 56. BGI Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 57. Diagnosis Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 58. Exact Sciences Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 59. AstraZeneca Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 60. Bayer AG Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 61. Johnson & Johnson Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 62. Pfizer Inc. Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Cancer Therapy and Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cancer Detection
Table 3. Key Players of Cancer Treatment
Table 4. Global Cancer Therapy and Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Cancer Therapy and Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Cancer Therapy and Testing Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Cancer Therapy and Testing Market Share by Region (2020-2025)
Table 8. Global Cancer Therapy and Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Cancer Therapy and Testing Market Share by Region (2026-2031)
Table 10. Cancer Therapy and Testing Market Trends
Table 11. Cancer Therapy and Testing Market Drivers
Table 12. Cancer Therapy and Testing Market Challenges
Table 13. Cancer Therapy and Testing Market Restraints
Table 14. Global Cancer Therapy and Testing Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Cancer Therapy and Testing Market Share by Players (2020-2025)
Table 16. Global Top Cancer Therapy and Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Therapy and Testing as of 2024)
Table 17. Ranking of Global Top Cancer Therapy and Testing Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Cancer Therapy and Testing Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Cancer Therapy and Testing, Headquarters and Area Served
Table 20. Global Key Players of Cancer Therapy and Testing, Product and Application
Table 21. Global Key Players of Cancer Therapy and Testing, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Therapy and Testing Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Cancer Therapy and Testing Revenue Market Share by Type (2020-2025)
Table 25. Global Cancer Therapy and Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Cancer Therapy and Testing Revenue Market Share by Type (2026-2031)
Table 27. Global Cancer Therapy and Testing Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Cancer Therapy and Testing Revenue Market Share by Application (2020-2025)
Table 29. Global Cancer Therapy and Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Cancer Therapy and Testing Revenue Market Share by Application (2026-2031)
Table 31. North America Cancer Therapy and Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Cancer Therapy and Testing Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Cancer Therapy and Testing Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Cancer Therapy and Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Cancer Therapy and Testing Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Cancer Therapy and Testing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Cancer Therapy and Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Cancer Therapy and Testing Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Cancer Therapy and Testing Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cancer Therapy and Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Cancer Therapy and Testing Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Cancer Therapy and Testing Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Cancer Therapy and Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Cancer Therapy and Testing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Cancer Therapy and Testing Market Size by Country (2026-2031) & (US$ Million)
Table 46. Invitae Company Details
Table 47. Invitae Business Overview
Table 48. Invitae Cancer Therapy and Testing Product
Table 49. Invitae Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 50. Invitae Recent Development
Table 51. Foundation Medicine Company Details
Table 52. Foundation Medicine Business Overview
Table 53. Foundation Medicine Cancer Therapy and Testing Product
Table 54. Foundation Medicine Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 55. Foundation Medicine Recent Development
Table 56. Guardant Health Company Details
Table 57. Guardant Health Business Overview
Table 58. Guardant Health Cancer Therapy and Testing Product
Table 59. Guardant Health Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 60. Guardant Health Recent Development
Table 61. Illumina Company Details
Table 62. Illumina Business Overview
Table 63. Illumina Cancer Therapy and Testing Product
Table 64. Illumina Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 65. Illumina Recent Development
Table 66. Sysmex Company Details
Table 67. Sysmex Business Overview
Table 68. Sysmex Cancer Therapy and Testing Product
Table 69. Sysmex Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 70. Sysmex Recent Development
Table 71. Abingdon Health Company Details
Table 72. Abingdon Health Business Overview
Table 73. Abingdon Health Cancer Therapy and Testing Product
Table 74. Abingdon Health Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 75. Abingdon Health Recent Development
Table 76. Sophia Company Details
Table 77. Sophia Business Overview
Table 78. Sophia Cancer Therapy and Testing Product
Table 79. Sophia Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 80. Sophia Recent Development
Table 81. NanoEntek Company Details
Table 82. NanoEntek Business Overview
Table 83. NanoEntek Cancer Therapy and Testing Product
Table 84. NanoEntek Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 85. NanoEntek Recent Development
Table 86. BGI Company Details
Table 87. BGI Business Overview
Table 88. BGI Cancer Therapy and Testing Product
Table 89. BGI Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 90. BGI Recent Development
Table 91. Diagnosis Company Details
Table 92. Diagnosis Business Overview
Table 93. Diagnosis Cancer Therapy and Testing Product
Table 94. Diagnosis Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 95. Diagnosis Recent Development
Table 96. Exact Sciences Company Details
Table 97. Exact Sciences Business Overview
Table 98. Exact Sciences Cancer Therapy and Testing Product
Table 99. Exact Sciences Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 100. Exact Sciences Recent Development
Table 101. AstraZeneca Company Details
Table 102. AstraZeneca Business Overview
Table 103. AstraZeneca Cancer Therapy and Testing Product
Table 104. AstraZeneca Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 105. AstraZeneca Recent Development
Table 106. Bayer AG Company Details
Table 107. Bayer AG Business Overview
Table 108. Bayer AG Cancer Therapy and Testing Product
Table 109. Bayer AG Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 110. Bayer AG Recent Development
Table 111. Johnson & Johnson Company Details
Table 112. Johnson & Johnson Business Overview
Table 113. Johnson & Johnson Cancer Therapy and Testing Product
Table 114. Johnson & Johnson Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 115. Johnson & Johnson Recent Development
Table 116. Pfizer Inc. Company Details
Table 117. Pfizer Inc. Business Overview
Table 118. Pfizer Inc. Cancer Therapy and Testing Product
Table 119. Pfizer Inc. Revenue in Cancer Therapy and Testing Business (2020-2025) & (US$ Million)
Table 120. Pfizer Inc. Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Cancer Therapy and Testing Picture
Figure 2. Global Cancer Therapy and Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cancer Therapy and Testing Market Share by Type: 2024 VS 2031
Figure 4. Cancer Detection Features
Figure 5. Cancer Treatment Features
Figure 6. Global Cancer Therapy and Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Cancer Therapy and Testing Market Share by Application: 2024 VS 2031
Figure 8. Lung Cancer Case Studies
Figure 9. Rectal Cancer Case Studies
Figure 10. Breast Cancer Case Studies
Figure 11. Other Case Studies
Figure 12. Cancer Therapy and Testing Report Years Considered
Figure 13. Global Cancer Therapy and Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Cancer Therapy and Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Cancer Therapy and Testing Market Share by Region: 2024 VS 2031
Figure 16. Global Cancer Therapy and Testing Market Share by Players in 2024
Figure 17. Global Top Cancer Therapy and Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Therapy and Testing as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Cancer Therapy and Testing Revenue in 2024
Figure 19. North America Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Cancer Therapy and Testing Market Share by Country (2020-2031)
Figure 21. United States Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Cancer Therapy and Testing Market Share by Country (2020-2031)
Figure 25. Germany Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Cancer Therapy and Testing Market Share by Region (2020-2031)
Figure 33. China Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Cancer Therapy and Testing Market Share by Country (2020-2031)
Figure 41. Mexico Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Cancer Therapy and Testing Market Share by Country (2020-2031)
Figure 45. Turkey Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Cancer Therapy and Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Invitae Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 49. Foundation Medicine Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 50. Guardant Health Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 51. Illumina Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 52. Sysmex Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 53. Abingdon Health Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 54. Sophia Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 55. NanoEntek Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 56. BGI Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 57. Diagnosis Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 58. Exact Sciences Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 59. AstraZeneca Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 60. Bayer AG Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 61. Johnson & Johnson Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 62. Pfizer Inc. Revenue Growth Rate in Cancer Therapy and Testing Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232